BackRevelation Biosciences- Units (1 Ord share & 1 War) Overview
Revelation Biosciences Inc - Units (1 Ord share & 1 War)

Revelation Biosciences- Units (1 Ord share & 1 War) Debt to Equity

Revelation Biosciences- Units (1 Ord share & 1 War) (REVBU) has a debt-to-equity ratio of 0.07, below the sector sector average of 0.2.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

0.07

Debt to Equity

0.07

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

Revelation Biosciences- Units (1 Ord share & 1 War) (REVBU) FAQ

As of the most recent data, REVBU shows a debt-to-equity ratio of 0.07. That is below the sector sector average of 0.2. Scroll down for historical charts and peer comparison views.

The its sector sector average debt-to-equity ratio is about 0.2. Revelation Biosciences- Units (1 Ord share & 1 War) is at 0.07, which is lower that average. That is roughly 63.6% below the sector mean. Use the comparison chart on this page to see how REVBU stacks up against individual peers as well.

Investors watch REVBU's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Revelation Biosciences- Units (1 Ord share & 1 War)'s latest reading is 0.07. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this debt-to-equity ratio page, Stockcircle has Revelation Biosciences- Units (1 Ord share & 1 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently 0.07) with ownership activity and broader fundamentals.